0000899243-15-002562.txt : 20150806
0000899243-15-002562.hdr.sgml : 20150806
20150806163207
ACCESSION NUMBER: 0000899243-15-002562
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150804
FILED AS OF DATE: 20150806
DATE AS OF CHANGE: 20150806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001338042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202960116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 500-7867
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weger Mary
CENTRAL INDEX KEY: 0001638460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34921
FILM NUMBER: 151033600
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-04
0
0001338042
Aegerion Pharmaceuticals, Inc.
AEGR
0001638460
Weger Mary
C/O AEGERION PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800
CAMBRIDGE
MA
02142
0
1
0
0
Chief Performance Officer
Stock Option (right to buy)
19.52
2015-08-04
4
A
0
40000
0.00
A
2025-08-04
Common Stock
40000
40000
D
The stock option award was made to the Reporting Person as part of a retention arrangement approved by the Issuer's Board of Directors on August 4, 2015.
The stock option award has an exercise price equal to the fair market value of the closing price of the Issuer on the date of the grant.
25% of the shares of common stock underlying this stock option award will vest on August 4, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through August 4, 2019, subject to the Reporting Person's continued employment with the Issuer.
/s/ Jennifer Fitzpatrick, as attorney-in-fact
2015-08-06